Neumora logomark
Skip to main content

Neumora

Pioneering a New Era of Precision Medicines for Brain Diseases

We are facing a global brain disease crisis, but we are lacking targeted, effective medicines. Patients deserve better.

Recent scientific and technological advancements have revolutionized precision medicines in oncology, and it’s time to develop precision medicines for brain diseases to change the status quo. 

Learn More

Neuroscience R&D. Redefined.

Today, neuropsychiatric disorders and neurodegenerative diseases are classified as broad disorders defined by clinical symptoms, leading to “one-size-fits-all” treatment approaches. In drug development, this has led to patient heterogeneity, subjective trial endpoints, and a lower likelihood of success. 

Through our proprietary precision data science platform, we aim to cut through brain disease heterogeneity to match the right patient populations to targeted therapeutics and increase the probability of developing effective medicines. Our platform integrates multiple types of data to create Data Biopsy Signatures™ and Precision Phenotypes™ to map disease drivers to the defined patient subtypes. 

Learn more

Brain diseases

don’t wait,

and neither will we.

We have assembled an exceptional team of data scientists, neuroscience drug developers, and company builders who have an unparalleled commitment to conquer one of the greatest medical challenges of our generation.

Revolutionize the future treatment of brain diseases with us.

Interested in joining our team?

Join Us

Featured News